Showing 411-420 of 1560 results for "".
Mastering the Sequence: CELMoDs Across Treatment Lines
https://reachmd.com/programs/cme/mastering-the-sequence-celmods-across-treatment-lines/36570/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivitySafety First: Navigating CELMoD-Associated Toxicities
https://reachmd.com/programs/cme/safety-first-navigating-celmod-associated-toxicities/36571/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityPrecision Targeting: Matching CELMoDs to the Right Patient With Myeloma
https://reachmd.com/programs/cme/precision-targeting-matching-celmods-to-the-right-patient-with-myeloma/36569/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityFar from the Flu: COVID-19's Mysterious Presenting Symptoms
https://reachmd.com/programs/covid-19-frontlines/far-flu-covid-19s-mysterious-presenting-symptoms/11345/Blanket claims of fever and a cough no longer suffice for describing the presenting symptoms of COVID-19. ENTs worldwide aim to do something about that.Emerging 'Bowel-Sparing' Procedures for Crohn's Disease
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/emerging-bowel-sparing-procedures-for-crohns-disease/10655/How can new alternatives being incorporated into surgical practice benefit your patients with Crohn's disease?Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
https://reachmd.com/programs/cme/beyond-the-joint-cross-specialty-solutions-for-advancing-tgct-patient-care/36596/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
https://reachmd.com/programs/cme/resectable-head-neck-cancer-a-team-based-approach-to-perioperative-immunotherapy/35705/Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative ImmunotherapyFaster Treatment of MI with the Help of Wireless EKG Programs
https://reachmd.com/programs/heart-matters/faster-treatment-of-mi-with-the-help-of-wireless-ekg-programs/6179/Door-to-balloon time for a patient with ST-segment elevation myocardial infarction (or STEMI) should be less than 90 minutes. Wireless electrocardiography (or EKG) programs around the country are helping to reduce door-to-balloon time by transmitting EKG data to hospitals via broadband internet, wheBridging the Gaps in Care: Key Posters from the 64th Annual ASH Meeting
https://reachmd.com/programs/ash-action-center/bridging-the-gaps-in-care-key-posters-from-the-64th-annual-ash-meeting/14200/Find out what we learned from the ASH Poster Walk on Diversity, Equity, and Inclusion in Hematologic Malignancies and Cellular Therapy.Visualizing the Beating Heart
https://reachmd.com/programs/clinicians-roundtable/visualizing-the-beating-heart/2952/Dr. Paul Iaizzo is the Principal Investigator of the Visible Heart Laboratory at the University of Minnesota. His laboratory has perfected use of large mammalian isolated heart models and conducts translational research from the cellular to the organ and whole body investigations. Dr. Iaizzo will di